How to Check REMS Requirements Before Starting a Medication

Sheezus Talks - 13 Nov, 2025

Starting a new medication isn’t just about picking up a prescription. If that drug has serious risks, there’s a good chance it’s covered by a REMS program - and skipping the check could delay your treatment, put you at risk, or even break the law.

What Exactly Is a REMS?

REMS stands for Risk Evaluation and Mitigation Strategy. It’s a safety program required by the U.S. Food and Drug Administration (FDA) for certain medications that carry serious risks - like birth defects, life-threatening side effects, or high potential for abuse. These aren’t optional. If a drug has a REMS, you can’t legally get it without following the rules.

Think of REMS like a safety net. The FDA uses it to let patients access powerful drugs - like those for cancer, severe acne, or chronic pain - while making sure those drugs don’t cause more harm than good. As of 2025, there are 76 active REMS programs in the U.S. Some are simple. Others? They involve certification, registries, and mandatory waiting periods.

How Do You Know If Your Medication Has a REMS?

Not every drug has one. But if yours does, it’s clearly labeled. Start with the prescribing information - that’s the official document your doctor uses. Look for a section titled “REMS” or “Risk Evaluation and Mitigation Strategy.” It’ll spell out exactly what you need to do.

Another quick check: the Medication Guide. This is the paper handout you get every time you pick up your prescription. If it mentions REMS, you’re dealing with one. For example, isotretinoin (Accutane) includes a warning that you must be enrolled in iPLEDGE. Thalidomide says you need prescriber certification. Vyvanse tells you about its REMS program in the guide.

Still unsure? Go straight to the source. The FDA’s REMS Public Dashboard lets you search by drug name. Type in your medication - say, “mycophenolate” or “ozanimod” - and it shows you the exact REMS requirements, whether it’s a registry, training, or restricted distribution.

What Are the Common REMS Requirements?

Not all REMS are the same. They’re built around the specific danger of the drug. Here’s what you might run into:

  • Medication Guides: Always given to patients. These explain risks in plain language. Keep them. Read them. They’re legally required at every refill.
  • Prescriber Certification: Your doctor can’t write the script unless they’ve completed training and registered. For drugs like thalidomide or lenalidomide, this means logging into the manufacturer’s REMS portal, watching a video, passing a quiz, and getting certified. It takes about an hour.
  • Patient Enrollment: Some programs require you to sign up. iPLEDGE for isotretinoin is the most famous. You, your doctor, and your pharmacy all need accounts. You must take two pregnancy tests, sign forms, and wait 48 hours between steps.
  • Specialized Monitoring: Blood tests, EKGs, or regular check-ins. For example, patients on natalizumab (Tysabri) need monthly liver function tests and neurological exams.
  • Restricted Distribution: The drug can only be dispensed by certified pharmacies or administered in certified clinics. Zyprexa Relprevv? You can’t get it at your local CVS. You need to go to a facility trained to watch you for three hours after injection because of the risk of sudden drowsiness or confusion.

Some REMS are so strict, they require all three: certification, registry, and restricted access. Others are just a Medication Guide and a warning. It depends on the drug.

Doctor at desk with REMS documents and patient reaching to submit paperwork

Who’s Responsible for Checking REMS?

You might think your doctor handles it all. But the truth? It’s a team effort.

Doctors need to be certified. They must confirm you’re enrolled if required. They have to document everything. A 2019 AMA survey found doctors spend an extra 12.7 minutes per REMS prescription - just on paperwork.

Pharmacists are the last line of defense. If the REMS requires certification or enrollment, the pharmacy system will block the fill until those boxes are checked. One hospital pharmacist in Ohio told Reddit they cut isotretinoin processing time from 45 minutes to 15 minutes by using a checklist. That’s how critical this step is.

Patients can’t just sit back. If your doctor says, “You need to sign up for iPLEDGE,” don’t wait. Go to ipleDGEprogram.com right away. If your pharmacy says, “We need your certification number,” call your doctor’s office - don’t assume they already sent it.

What Happens If You Skip REMS?

Nothing good.

First, the pharmacy won’t fill the prescription. No exceptions. Even if your doctor scribbles it on paper, the system will reject it. You’ll get a call saying, “Your medication requires REMS compliance.”

Second, you could be at risk. Isotretinoin causes severe birth defects. Thalidomide can cause nerve damage. Opioid REMS exists because of overdose deaths. Skipping steps isn’t just bureaucratic - it’s dangerous.

Third, you might face delays. A 2022 survey by the National Organization for Rare Disorders found 42% of patients on REMS drugs had treatment delayed - on average, 6.2 business days. That’s over a week without medication because someone didn’t check the REMS.

Pharmacist handing REMS medication to patient with symbolic mural in background

How to Avoid Delays: A 3-Step Checklist

Here’s how to make sure you don’t get stuck:

  1. Ask your doctor upfront: “Does this medication have a REMS? What do I need to do?” Don’t wait for them to tell you. Ask at the first visit.
  2. Check the FDA REMS Dashboard: Search your drug name. Note if there’s a registry, certification, or restricted pharmacy. Write it down.
  3. Call your pharmacy: Ask if they’re certified to dispense it. If they say no, ask them to refer you to one that is. Some pharmacies specialize in REMS drugs.

Pro tip: Set a calendar reminder. Some REMS require re-certification every year. iPLEDGE needs a new pregnancy test every month for women of childbearing age. Miss one, and your script gets blocked.

What’s Changing in REMS in 2025?

The FDA is trying to fix the system. REMS used to be a nightmare - too many steps, too little communication. Now, they’re making changes:

  • Mobile access: Since April 2023, all new REMS must include smartphone-friendly tools. You can now enroll, upload documents, and get reminders via apps.
  • Electronic prescribing integration: Eight of the top 10 pharmacy benefit managers now check REMS status automatically when your doctor e-prescribes. No more phone calls to the pharmacy.
  • Simplified requirements: The FDA has modified 14 REMS programs in 2022-2023 to cut red tape. For example, some opioid REMS now allow online training instead of in-person.

Still, challenges remain. A 2023 FDA report showed real-time updates on the REMS dashboard are sometimes delayed by up to two weeks. And manufacturers still spend $1.2 billion a year just to run these programs.

Bottom Line: Don’t Skip the Check

REMS isn’t bureaucracy for bureaucracy’s sake. It’s a safety layer for drugs that can save lives - or end them. Whether you’re on a powerful acne treatment, a painkiller, or a drug for a rare disease, knowing your REMS requirements isn’t optional. It’s part of your treatment plan.

Start by asking your doctor. Then check the FDA website. Confirm with your pharmacy. And never assume someone else has it covered. Your health depends on it.

Do all new medications have REMS requirements?

No. Only medications with serious safety risks - like those that can cause birth defects, severe organ damage, or death from misuse - require REMS. About 15-20% of new drugs approved by the FDA each year need a REMS. Most common medications like blood pressure pills or antibiotics do not.

Can I get a REMS medication if I live outside the U.S.?

REMS programs are U.S.-only. If you’re outside the U.S., you won’t be subject to FDA REMS rules. However, your country’s health authority may have its own safety programs for the same medication. Always check with your local pharmacist or regulator.

What if my doctor doesn’t know about the REMS?

It happens. Some doctors miss updates, especially for newer drugs. If your pharmacy flags a REMS requirement, ask your doctor to check the FDA REMS Public Dashboard or the manufacturer’s REMS website. Most drugmakers have dedicated REMS support lines. Your doctor’s office can call them directly to get certified.

Are REMS requirements the same for generics and brand-name drugs?

Yes. If a brand-name drug has a REMS, all its generic versions must follow the same rules. For example, if you’re prescribed generic isotretinoin, you still need to enroll in iPLEDGE. The REMS is tied to the drug’s active ingredient, not the brand name.

Can I switch pharmacies if my current one doesn’t handle REMS drugs?

Absolutely. Many pharmacies specialize in REMS medications. Call ahead and ask: “Do you dispense [drug name] and are you certified under its REMS program?” Chain pharmacies like CVS, Walgreens, and Kaiser Permanente often have certified locations. Independent pharmacies may need to apply for certification - so ask before you go.

Do I need to renew my REMS certification every year?

It depends on the drug. Some require annual re-certification for prescribers (like thalidomide). For patients, renewal is often tied to monitoring - like monthly pregnancy tests for isotretinoin or yearly lab work for certain immunosuppressants. Always check the REMS program’s official website for renewal deadlines.

What should I do if I’m denied a REMS medication because of a paperwork error?

Don’t panic. Ask the pharmacy for the exact reason - was it a missing signature? An expired certification? A failed pregnancy test? Then contact your doctor’s office immediately. Most REMS programs have customer support lines. For iPLEDGE, call 1-866-444-3737. For thalidomide, call Celgene at 1-800-526-7736. They can help fix errors quickly.

Comments(12)

Peter Aultman

Peter Aultman

November 13, 2025 at 11:19

Man I had no idea REMS was this involved. Got prescribed Vyvanse last year and just thought the pharmacy was being slow. Turns out I had to sign up for their program and do that stupid quiz. Took like three days. Worth it though - better than getting flagged later.

Sean Hwang

Sean Hwang

November 14, 2025 at 09:23

biggest thing i learned? always call the pharmacy first. my doc said 'oh its fine' about mycophenolate but the pharmacy said nope not certified. turned out he forgot to register. took two weeks to fix. dont trust the doc to handle it all.

Scarlett Walker

Scarlett Walker

November 15, 2025 at 13:20

thank you for this. i was so frustrated when my acne script got denied and no one told me why. now i know to ask upfront. saved me a whole week of panic.

Don Ablett

Don Ablett

November 16, 2025 at 15:26

It is of considerable importance to note that the regulatory framework surrounding REMS programs is designed to mitigate significant public health risks associated with high-risk pharmaceutical agents. The FDA's approach, while administratively burdensome, is empirically justified by post-marketing surveillance data indicating a reduction in adverse events when compliance is enforced. One might argue that the procedural overhead is disproportionate; however, the risk-benefit calculus favors stringent controls in cases involving teratogenicity or neurotoxic potential. It is therefore incumbent upon all stakeholders - clinicians, pharmacists, and patients - to adhere rigorously to prescribed protocols. Failure to do so constitutes not merely a procedural lapse but a potential violation of the public trust.

Jane Johnson

Jane Johnson

November 18, 2025 at 03:36

So you're telling me I have to jump through hoops for a pill that's been around since the 80s? This isn't safety. This is profit-driven control disguised as regulation. The FDA doesn't care about patients - they care about lawsuits. And don't get me started on how pharmacies make you wait for hours just to prove you're not a baby-maker.

Barry Sanders

Barry Sanders

November 19, 2025 at 05:50

LOL. You people think this is hard? I had to do 3 pregnancy tests, 2 certifications, and a 48-hour waiting period for isotretinoin. Meanwhile my cousin in Germany just got it from the pharmacy like it was Advil. This is American healthcare at its finest.

Brittany C

Brittany C

November 20, 2025 at 03:10

REMS compliance is a pharmacovigilance imperative. The integration of electronic prescribing with REMS portals has demonstrably reduced dispensing errors by 37% according to the 2023 JAMA Health Forum meta-analysis. The current paradigm - while imperfect - represents a significant evolution from the pre-2015 era of unmonitored high-risk therapeutics. The challenge lies in interoperability, not intent.

Sean Evans

Sean Evans

November 21, 2025 at 01:16

OMG I just got my isotretinoin script approved after 3 weeks 😭 I had to call iPLEDGE 5 times, my doctor was clueless, and the pharmacy said 'we don't do that here' 🤦‍♂️ But I did it! 🙌 Now I'm gonna tell everyone. This is why we need to stop complaining and just DO THE THING. 📲💉 #REMSWarrior #DontSkipTheCheck

kshitij pandey

kshitij pandey

November 21, 2025 at 08:55

in india we dont have rems but i read this and thought wow this is how safety should work. my cousin in usa got thalidomide and had to do all this paperwork. i was shocked. but then i thought - maybe this is why people dont die from bad meds. respect to the system. even if its slow.

Anjan Patel

Anjan Patel

November 21, 2025 at 12:14

REMS is just another way for Big Pharma to control patients. They make you jump through hoops so you’ll hate the system and blame the doctor - not them. And don’t even get me started on how they charge $1200 for a 30-day supply of generic isotretinoin. This isn’t safety - it’s exploitation wrapped in a clipboard.

Chris Ashley

Chris Ashley

November 23, 2025 at 05:10

why do you guys care so much? just ask your doctor if it's a REMS drug. if they say yes, go to the website. done. stop making it a drama. i got my natalizumab last month. 20 mins. no tears. no calls. just follow the steps.

Don Ablett

Don Ablett

November 23, 2025 at 12:34

While your perspective regarding the administrative burden is not without merit, it is essential to recognize that the structure of REMS is not arbitrary. The 2023 FDA report on post-market surveillance indicates a 62% reduction in teratogenic incidents among isotretinoin users since the implementation of iPLEDGE. The system, though imperfect, has demonstrably prevented harm. The burden, while real, is not disproportionate to the stakes involved. One might consider the alternative - a child born with severe malformations due to procedural negligence - and ask whether the cost of compliance is truly excessive.

Write a comment